Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parallel Effects of Ketamine and Schizophrenia on Neurocognitive Function
NCT02675530Phase 1Completed
- Sponsor
- Yale University
- Start
- Dec 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ketamine (2 arms), sponsored by Yale University. Primary endpoint: P300 Event-Related Potential. Started Dec 2007; status: completed.
02
Drugs
ketamine
Beyond the preview
Go deeper on NCT02675530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675530.